Tag: OTC:SNANF

August 25, 2020

Sona Nanotech Announces Clinical Evaluation Study Results for its COVID-19 Antigen Test

Sona Nanotech is pleased to announce that its rapid detection COVID-19 antigen test achieved a sensitivity of 84.6% and a...
August 25, 2020

Why Invest in Nanotech Stocks?

Nanotech benefits areas as diverse as cancer therapies and solar energy solutions. Here's why you should consider nanotech stocks.
May 12, 2020

Sona Nanotech Provides COVID-19 Antigen Test Progress Update

Sona Nanotech is pleased to provide the following update on the development of its rapid-response, COVID-19 antigen test.
April 13, 2020

Sona Nanotech Provides a Progress Update on its Covid-19 Antigen Test

Sona Nanotech (CSE:SONA) provides an update on the development, manufacturing arrangements and pre-orders for its Covid-19 antigen test.
March 31, 2020

Sona Nanotech Awarded $4.1 Million from NGen for Rapid Development and Launch of COVID-19 Antigen Test

Sona Nanotech Inc. (CSE:SONA), (OTC:SNANF) has been awarded a $4.1 million grant to develop and commercialize its Covid-19 rapid-response antigen...
March 30, 2020

Sona Nanotech Enters into a Manufacturing Service Agreement and a Sale Letter of Intent Agreement for 2mm Tests

Sona Nanotech Inc. (CSE:SONA), (OTC:SNANF) (the "Company") entered into service and supply agreements with a contract manufacturing organization (CMO) in...
March 20, 2020

Sona Nanotech Obtains New OTC Trading Symbol

Sona Nanotech Inc. (CSE:SONA, OTC:SNANF) is pleased to announce that it has undertaken to further develop the U.S. trading market...